ESSA Pharma Inc.
-
Ticker
EPIX
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Vancouver, British Columbia
ESSA is a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer. ESSA’s lead clinical candidate, EPI-7386, represents a new approach to disrupting androgen receptor signaling pathway, the primary driver of prostate cancer growth.
ESSA Pharma Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports